Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADVFN Regulatory News (AFN)

  • There is currently no data for AFN

Board change

24 Feb 2022 07:00

RNS Number : 6393C
ADVFN PLC
24 February 2022
 

24 February 2022

For immediate release

ADVFN PLC

("ADVFN" or the "Company")

Board change

 

As announced on 23 February 2022, the Board has been considering how best to proceed in the light of the proposed Board changes proposed by Mr Yair Tauman. Against this background, the Board has decided that the continuing uncertainty regarding the Board composition is not in the best interests of the Company or its shareholders, employees or other stakeholders. Accordingly, the Board and Clem Chambers have agreed that Clem Chambers will step down as Chief Executive of ADVFN and resign all his group directorships with effect from 28 February 2022. The Board believes that this will make any management transition less disruptive for the Company and Jon Mullins, an existing director of the Company, has been appointed as Chief Executive with effect from 28 February 2022.

 

Clem Chambers has agreed to support the Company in its management transition to enable an orderly handover to Jon Mullins and the wider ADVFN management team. It is expected that in due course any ongoing support by Clem Chambers will be formalised in a consulting agreement on terms yet to be agreed. As also previously announced, the Board is seeking the information required for AIM-compliance purposes from the directors proposed by Mr Yair Tauman to be put up for election and a further announcement will be made in due course.

 

Michael Hodges, Chairman of ADVFN, stated:

 

"On behalf of ADVFN, I would like to thank Clem for his all his time and effort over the last 20 years. He will be missed and we wish him all the best for the future." 

 

The Board, having taken legal advice in respect of the applicable compensation for loss of office due to Clem Chambers, has agreed compensation with Clem Chambers within his contractual entitlement under which he will receive one year's salary paid in full and one year's salary settled in new ordinary shares in ADVFN. Pursuant to the compromise agreement entered into with Clem Chambers, the Board has therefore issued 592,419 new ADVFN ordinary shares at a price of 70.19p per share (being the volume weighted average closing mid-market price for the two-week period prior to the publication of this announcement), amounting to £415,819 ("Settlement Shares").

 

The Settlement Shares represent 2.27 per cent. of the existing issued share capital of the Company and Clem Chambers has agreed not to dispose of any interest in the Settlement Shares for a period of six months. The Settlement Shares will rank pari passu with the existing Ordinary Shares in issue. Application will be made for the Settlement Shares to be admitted to trading on AIM and it is expected that Admission will become effective and dealings will commence on or around 2nd March 2022.

 

 

Enquiries:

For further information please contact:

 

ADVFN PLC

Michael Hodges

+44 (0) 203 8794 460

 

Beaumont Cornish Limited (Nominated Adviser)

www.beaumontcornish.com

Roland Cornish/Michael Cornish

+44 (0) 207 628 3396

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. The person who arranged for the release of this announcement on behalf of the Company was Clem Chambers, Director.

 

A copy of this announcement is available on the Group's websitewww.ADVFNPLC.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABKNBPNBKBPBB
Date   Source Headline
6th May 20257:00 amRNSCancellation - ADVFN PLC
30th Apr 20256:00 pmRNSADVFN
28th Apr 20257:00 amRNSResult of Meeting
24th Apr 202512:00 pmRNSHolding(s) in Company
23rd Apr 20251:00 pmRNSHolding(s) in Company
27th Mar 20257:00 amRNSProposed cancellation of admission to AIM
27th Mar 20257:00 amRNSHalf-year Report
27th Jan 20255:35 pmRNSCorporate update
10th Jan 20256:08 pmRNSDirectorate Change
17th Dec 20245:00 pmRNSResult of AGM
3rd Dec 20246:27 pmRNSDirector/PDMR Shareholding
3rd Dec 20246:20 pmRNSDirector/PDMR Shareholding
22nd Nov 20243:00 pmRNSNotice of AGM
21st Nov 20242:05 pmRNSFinal Results
24th Oct 20247:00 amRNSMobile app / live chat rollout and trading update
23rd Jul 202410:00 amRNSCorporate update
4th Jul 20241:11 pmRNSHolding(s) in Company
6th Jun 20247:00 amRNSHolding(s) in Company
4th Jun 202411:00 amRNSTotal Voting Rights
3rd Jun 20247:00 amRNSDirectorate Change
21st May 20247:00 amRNSDirector/PDMR Shareholding
16th May 20247:00 amRNSIssue of Equity
21st Mar 20249:49 amRNSHalf-year Report
9th Feb 202411:19 amRNSNew ADVFN Italia website is launched
12th Jan 20242:00 pmRNSResult of Meeting
28th Dec 20231:10 pmRNSResult of AGM
21st Dec 20237:00 amRNSFinal Results
5th Dec 20234:00 pmRNSNotice of AGM
16th Nov 20231:30 pmRNSHolding(s) in Company
21st Sep 202312:00 pmRNSADFVN connects audience to Doceo content
15th Aug 20236:05 pmRNSCorporate update
9th Jun 20236:15 pmRNSDirector/PDMR Shareholding
2nd Jun 202312:14 pmRNSTrading and corporate update
16th May 20234:33 pmRNSHolding(s) in Company
5th May 20233:06 pmRNSTotal Voting Rights
4th Apr 20237:00 amRNSIssue of Equity
30th Mar 20232:07 pmRNSHolding(s) in Company
30th Mar 20232:05 pmRNSHolding(s) in Company
23rd Mar 20235:02 pmRNSHolding(s) in Company
23rd Mar 20235:01 pmRNSHolding(s) in Company
23rd Mar 20235:00 pmRNSHolding(s) in Company
23rd Mar 20233:30 pmRNSDirector/PDMR Shareholding
20th Mar 20236:20 pmRNSAdmission update
14th Mar 202312:05 pmRNSFurther equity issue under the Open Offer
6th Mar 20237:00 amRNSHalf-year Report
6th Feb 202311:53 amRNSDirectorate Change
13th Jan 202311:19 amRNSResult of AGM
11th Jan 20231:15 pmRNSHolding(s) in Company
11th Jan 202311:10 amRNSHolding(s) in Company
11th Jan 202311:10 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.